Abstract

In this paper, composite systems containing curcumin (CUR) were prepared through supercritical-assisted atomization (SAA), using different carriers. Curcumin is particularly interesting in the pharmaceutical and nutraceutical fields for its antioxidant, antitumoral, and anti-inflammatory properties. However, its therapeutic effect on human health is restricted by its poor water solubility and low dissolution rate, limiting its absorption after its oral administration. To increase the dissolution rate and then the bioavailability of the active compound, CUR was coprecipitated with polymeric, i.e., polyvinylpyrrolidone (PVP) and dextran (DXT), and not polymeric, i.e., hydroxypropyl-β-cyclodextrin (HP-β-CD), carriers. The effects of some operating parameters, namely the concentration of solutes in solution and the active compound/carrier ratio, on the morphology and the particle size distribution of the powders were investigated. Submicrometric particles were produced with all the carriers. Under the best operating conditions, the mean diameters ± standard deviation were equal to 0.69 ± 0.20 μm, 0.40 ± 0.13 μm, and 0.81 ± 0.25 μm for PVP/CUR, DXT/CUR, and HP-β-CD/CUR, respectively. CUR dissolution rates from coprecipitated particles were significantly increased in the case of all the carriers. Therefore, the results are exciting from a pharmaceutical and nutraceutical point of view, to produce supplements containing curcumin, but assuring a high dissolution rate and bioavailability and, consequently, a more effective therapeutic effect.

Highlights

  • Curcumin (CUR) is a polyphenol of plant origin and is the main component of turmeric (Curcuma longa), used in traditional Asian medicine to treat multiple health problems

  • As is well known to all, the gravity of the recent pandemic has heavily directed the interest of the world scientific community in the search for treatments and vaccines for the treatment of Coronavirus-2019 (COVID-19) disease, caused by SARS-CoV-2

  • This paper aimed to evaluate the carrier’s effect and optimize the operating conditions to obtain a rapid release of CUR

Read more

Summary

Introduction

Curcumin (CUR) is a polyphenol of plant origin and is the main component of turmeric (Curcuma longa), used in traditional Asian medicine to treat multiple health problems. The scientific community’s interest in CUR is linked to its anti-inflammatory, antioxidant, anticarcinogenic, and neuroprotective properties [1,2]. Some studies have shown the beneficial effects of CUR against viral infections of the respiratory tract [3]. In 2013, Barnard and Kumaki reviewed efficacious anti-severe acute respiratory syndrome coronavirus (SARS-CoV) therapies [4]; among various antiviral agents, CUR is listed as one of the natural products that inhibit SARS-CoV. As is well known to all, the gravity of the recent pandemic has heavily directed the interest of the world scientific community in the search for treatments and vaccines for the treatment of Coronavirus-2019 (COVID-19) disease, caused by SARS-CoV-2. The authors highlighted that CUR could hinder the cell entry and the replication of SARS-CoV-2, and prevent and repair damage associated with COVID-19 [5].

Objectives
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call